Paler, Marissa .

HRN: 28-69-34  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2026
CEFTAZIDIME 1GM (VIAL)
03/15/2026
03/21/2026
IV
1g
Q8
Pneumonia
Pending Pharmacy Acceptance 

 Indication:  Empiric Then Culture-directed    Type of Infection:  Pneumonia    Compliance to guidelines: